183 related articles for article (PubMed ID: 10510148)
1. A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening.
Danjou P; Paty I; Fruncillo R; Worthington P; Unruh M; Cevallos W; Martin P
Br J Clin Pharmacol; 1999 Sep; 48(3):367-74. PubMed ID: 10510148
[TBL] [Abstract][Full Text] [Related]
2. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.
Verster JC; Volkerts ER; Schreuder AH; Eijken EJ; van Heuckelum JH; Veldhuijzen DS; Verbaten MN; Paty I; Darwish M; Danjou P; Patat A
J Clin Psychopharmacol; 2002 Dec; 22(6):576-83. PubMed ID: 12454557
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.
Troy SM; Lucki I; Unruh MA; Cevallos WH; Leister CA; Martin PT; Furlan PM; Mangano R
J Clin Psychopharmacol; 2000 Jun; 20(3):328-37. PubMed ID: 10831020
[TBL] [Abstract][Full Text] [Related]
4. Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening.
Hindmarch I; Patat A; Stanley N; Paty I; Rigney U
Hum Psychopharmacol; 2001 Mar; 16(2):159-167. PubMed ID: 12404586
[TBL] [Abstract][Full Text] [Related]
5. Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening.
Zammit GK; Corser B; Doghramji K; Fry JM; James S; Krystal A; Mangano RM
J Clin Sleep Med; 2006 Oct; 2(4):417-23. PubMed ID: 17557470
[TBL] [Abstract][Full Text] [Related]
6. Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon.
Stone BM; Turner C; Mills SL; Paty I; Patat A; Darwish M; Danjou P
Br J Clin Pharmacol; 2002 Feb; 53(2):196-202. PubMed ID: 11851645
[TBL] [Abstract][Full Text] [Related]
7. Effects of zolpidem and zaleplon on cognitive performance after emergent morning awakenings at Tmax: a randomized placebo-controlled trial.
Dinges DF; Basner M; Ecker AJ; Baskin P; Johnston SL
Sleep; 2019 Mar; 42(3):. PubMed ID: 30576525
[TBL] [Abstract][Full Text] [Related]
8. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.
Greenblatt DJ; Harmatz JS; von Moltke LL; Ehrenberg BL; Harrel L; Corbett K; Counihan M; Graf JA; Darwish M; Mertzanis P; Martin PT; Cevallos WH; Shader RI
Clin Pharmacol Ther; 1998 Nov; 64(5):553-61. PubMed ID: 9834048
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic profile of Zaleplon, a new non-benzodiazepine hypnotic agent.
Patat A; Paty I; Hindmarch I
Hum Psychopharmacol; 2001 Jul; 16(5):369-392. PubMed ID: 12404558
[TBL] [Abstract][Full Text] [Related]
10. The effect of two benzodiazepine receptor agonist hypnotics on sleep-dependent memory consolidation.
Hall-Porter JM; Schweitzer PK; Eisenstein RD; Ahmed HA; Walsh JK
J Clin Sleep Med; 2014 Jan; 10(1):27-34. PubMed ID: 24426817
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacodynamics of Ro 41-3696, a new hypnotic, and zolpidem after night-time administration to healthy subjects.
Dingemanse J; Bury M; Bock J; Joubert P
Psychopharmacology (Berl); 1995 Nov; 122(2):169-74. PubMed ID: 8848532
[TBL] [Abstract][Full Text] [Related]
12. The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis.
Stranks EK; Crowe SF
J Clin Exp Neuropsychol; 2014; 36(7):691-700. PubMed ID: 24931450
[TBL] [Abstract][Full Text] [Related]
13. Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg.
Allain H; Bentué-Ferrer D; Breton SL; Polard E; Gandon JM
Hum Psychopharmacol; 2003 Jul; 18(5):369-74. PubMed ID: 12858323
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers.
Blin O; Micallef J; Audebert C; Legangneux E
J Clin Psychopharmacol; 2006 Jun; 26(3):284-9. PubMed ID: 16702893
[TBL] [Abstract][Full Text] [Related]
15. Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol.
Vermeeren A; Riedel WJ; van Boxtel MP; Darwish M; Paty I; Patat A
Sleep; 2002 Mar; 25(2):224-31. PubMed ID: 11905433
[TBL] [Abstract][Full Text] [Related]
16. Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo.
Allain H; Bentué-Ferrer D; Tarral A; Gandon JM
Eur J Clin Pharmacol; 2003 Jul; 59(3):179-88. PubMed ID: 12756510
[TBL] [Abstract][Full Text] [Related]
17. Residual effects of zolpidem, triazolam, rilmazafone and placebo in healthy elderly subjects: a randomized double-blind study.
Uemura SI; Kanbayashi T; Wakasa M; Satake M; Ito W; Shimizu K; Shioya T; Shimizu T; Nishino S
Sleep Med; 2015 Nov; 16(11):1395-1402. PubMed ID: 26498242
[TBL] [Abstract][Full Text] [Related]
18. Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance.
Paul MA; Gray G; Kenny G; Pigeau RA
Aviat Space Environ Med; 2003 Dec; 74(12):1263-70. PubMed ID: 14692469
[TBL] [Abstract][Full Text] [Related]
19. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
Elie R; Rüther E; Farr I; Emilien G; Salinas E
J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
[TBL] [Abstract][Full Text] [Related]
20. Zaleplon: a review of its use in the treatment of insomnia.
Dooley M; Plosker GL
Drugs; 2000 Aug; 60(2):413-45. PubMed ID: 10983740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
